BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38281224)

  • 1. Correlation of PTEN signaling pathway and miRNA in breast cancer.
    Mohammadi M; Fazilat A; Mamalo AS; Ojarudi M; Hemmati-Dinarvand M; Beilankouhi EAV; Valilo M
    Mol Biol Rep; 2024 Jan; 51(1):221. PubMed ID: 38281224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.
    Abadi AJ; Zarrabi A; Gholami MH; Mirzaei S; Hashemi F; Zabolian A; Entezari M; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
    Hu M; Zhu S; Xiong S; Xue X; Zhou X
    Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
    Wang F; Li L; Chen Z; Zhu M; Gu Y
    Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-548k suppresses apoptosis in breast cancer cells by affecting PTEN/PI3K/AKT signaling pathway.
    Yadollahi-Farsani M; Amini-Farsani Z; Moayedi F; Khazaei N; Yaghoobi H
    IUBMB Life; 2023 Feb; 75(2):97-116. PubMed ID: 36309967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis.
    Ibrahim HM; Ismail MB; Ammar RB; Ahmed EA
    Biochem Cell Biol; 2021 Jun; 99(3):374-384. PubMed ID: 33103467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
    Liu C; Liu Z; Li X; Tang X; He J; Lu S
    Oncol Rep; 2017 Oct; 38(4):2435-2443. PubMed ID: 28791363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA‑25‑3p inhibits the proliferation and promotes the apoptosis of multiple myeloma cells via targeting the PTEN/PI3K/AKT signaling pathway.
    Zi Y; Zhang Y; Wu Y; Zhang L; Yang R; Huang Y
    Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33448321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
    Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y
    Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism.
    Zheng H; Liu J; Tycksen E; Nunley R; McAlinden A
    Bone; 2019 Jun; 123():92-102. PubMed ID: 30898695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.
    Wang H; Zhang Q; Cui W; Li W; Zhang J
    Cell Cycle; 2021 Oct; 20(20):2125-2136. PubMed ID: 34570663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.